Universal Controlled Laboratory Reactor Simplifies Synthesis Scale-up
November 19, 2015
The ReactoMate "Datum" is a new compact benchtop Controlled Lab Reactor (CLR) system from Asynt that offers the flexibility to accommodate reaction vessels from 100ml to 5 litres. Reaction vessels from Asynt, and its partner AG!, can be easily exchanged on the ReactoMate "Datum" allowing chemists to quickly change between reactor vessel sizes thereby enabling [...]
Qlucore invests in development and USA
November 18, 2015
Rights issue and development loan fund expansion in software team and US salesforce Qlucore, a world leader in the development of bioinformatics software enhances its financial position with a combination of a rights issue and a development loan from Swedish regional development fund ALMI. Investment from the two sources is EURO 545,000. This injection of [...]
Tecan adds the personal touch to wine microbiology
November 18, 2015
The Wine Microbiology and Microbial Biotechnology Laboratory at the University of Adelaide has developed a customized solution offering fully automated sampling for yeast fermentations. Based on a Freedom EVO® 200 platform, this system frees researchers from the need to manually aliquot samples day and night for up to three weeks. Dr Tommaso Liccioli Watson, a [...]
CROWN BIOSCIENCE OFFERS UNIQUE IMMUNO-ONCOLOGY TRANSLATIONAL RESEARCH PLATFORM
November 18, 2015
SANTA CLARA, CALIF. — CROWN BIOSCIENCE, A GLOBAL DRUG DISCOVERY AND DEVELOPMENT SERVICES COMPANY PROVIDING TRANSLATIONAL PLATFORMS TO ADVANCE ONCOLOGY AND METABOLIC DISEASE RESEARCH, NOW PROVIDES A COMPREHENSIVE IMMUNO-ONCOLOGY TRANSLATIONAL RESEARCH PLATFORM. “Crown’s suite of in vitro and in vivo immuno-oncology assays employing translational experimental models help inform and accelerate the development of cancer immunotherapies [...]
Meridian Receives FDA Clearance for New Molecular Whooping Cough Test Claims
November 18, 2015
CINCINNATI -- Meridian Bioscience, Inc. (NASDAQ: VIVO) today announced it has received clearance from theU.S. Food and Drug Administration (FDA) for new claims for its illumigene® Pertussis molecular amplification test. The upgraded test reduces the effect of inhibitors in biologic samples and significantly expands Meridian’s customer base by including specimens collected by ESwab™ (Copan Diagnostics, [...]
November 18, 2015
ALAMEDA, Calif. -- BioTime, Inc. (NYSE MKT and TASE: BTX), a clinical-stage regenerative medicine company with a focus on pluripotent stem cell technology, today announced that the Company’s Board of Directors has appointed Russell Skibsted to the position of Chief Financial Officer, succeeding Robert Peabody. Mr. Russell Skibsted brings over 25 years of financial management [...]
EM Resolutions: New TEM grids for FIB lift-out procedures
November 18, 2015
Saffron Walden, UK: EM Resolutions, manufacturers and suppliers of tools and accessories for users of electron microscopes, announce the availability of EM-Tec FIB grids which offer a secure way to attach TEM lamellas to the posts during lift-out procedures with FIB or SEM/FIB systems. The new EM-Tec range of FIB lift-out grids from EM Resolutions [...]
Merck KGaA Completes $17B Sigma-Aldrich Acquisition
November 18, 2015
NEW YORK – Germany's Merck KGaA today announced the completion of its $17 billion acquisition of Sigma-Aldrich, following approval from the European Commission. The deal creates a science sector giant that will "cover every step of the biotech production chain," Merck said in a statement. The company will have around 50,000 employees in 67 countries, [...]
November 17, 2015
PARIS & RADNOR, Pa. -- Air Liquide (Euronext Paris:AI), world leader in gases, technologies and services for Industry and Health, and Airgas (NYSE:ARG), one of the leading suppliers of industrial gases and associated products and services in the U.S., today announced an agreement under which Air Liquide will acquire Airgas. Airgas shareholders will receive $143 [...]
Kymab Implements Genedata Biologics for High-throughput Antibody Discovery
November 17, 2015
Basel, Switzerland -- Genedata, a leading provider of advanced software solutions for drug discovery and life science research, today announced that Kymab Ltd. has licensed Genedata Biologics™ for use in their proprietary antibody discovery programs. The platform will support biopharma R&D operations from early B-cell and hybridoma screening, to antibody engineering, expression, purification, and analytics. [...]
